59 related articles for article (PubMed ID: 38520551)
1. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling.
Liu C; Zhou J; Zhang S; Fu J; Li Y; Hao Y; Yuan J; Tang F; Ge W; He H; Chen Q
Oral Dis; 2024 May; 30(4):2097-2109. PubMed ID: 37249062
[TBL] [Abstract][Full Text] [Related]
2. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention.
Qin Y; Li Z; Liu T; Ma J; Liu H; Zhou Y; Wang S; Zhang L; Peng Q; Ye P; Duan N; Wang W; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):206. PubMed ID: 38644421
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.
Fukuyama T; Ichiki Y; Yamada S; Shigematsu Y; Baba T; Nagata Y; Mizukami M; Sugaya M; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Cancer Sci; 2007 Jul; 98(7):1048-54. PubMed ID: 17511773
[TBL] [Abstract][Full Text] [Related]
4. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation.
Takaishi K; Komohara Y; Tashiro H; Ohtake H; Nakagawa T; Katabuchi H; Takeya M
Cancer Sci; 2010 Oct; 101(10):2128-36. PubMed ID: 20860602
[TBL] [Abstract][Full Text] [Related]
5. The potential mechanism of WT1-associated protein-induced N-6-methyladenosine modification of colony-stimulating factor 2 in the progression of oral squamous cell carcinoma by JAK/STAT3 pathway regulation.
Peng R; Jiang S; Jin Z
Eur J Oral Sci; 2024 Jun; ():e13001. PubMed ID: 38831514
[TBL] [Abstract][Full Text] [Related]
6. Association of COX-2, TNF-α, TLR4, and IKKα With Survival of Patients With Oral Squamous Cell Carcinomas: A Systematic Review.
Biasin FF; Franco AM; Louzeiro GC; Cherubini K; Salum FG
Asian Pac J Cancer Prev; 2024 Mar; 25(3):757-766. PubMed ID: 38546058
[TBL] [Abstract][Full Text] [Related]
7. STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.
Jiang M; Li B
Cells; 2022 Oct; 11(19):. PubMed ID: 36231093
[TBL] [Abstract][Full Text] [Related]
8. Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC.
Lenka S; Bhola RK; Varanasi PR; Bhuyan SK; Bhuyan R
Med Oncol; 2023 Apr; 40(5):134. PubMed ID: 37010645
[TBL] [Abstract][Full Text] [Related]
9. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.
Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
[TBL] [Abstract][Full Text] [Related]
11. Oct4 downregulation-induced inflammation increases the migration and invasion rate of oral squamous cell carcinoma.
Sun S; Yang H; Wang F; Zhao S
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1440-1449. PubMed ID: 34553218
[TBL] [Abstract][Full Text] [Related]
12. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
14. ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC.
Wang J; Man Q; Zhong N; Wang H; Zhang C; Li S; Bu L; Liu B
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361568
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways.
Chuangchot N; Jamjuntra P; Yangngam S; Luangwattananun P; Thongchot S; Junking M; Thuwajit P; Yenchitsomanus PT; Thuwajit C
Breast Cancer Res; 2023 Jul; 25(1):86. PubMed ID: 37480115
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
